Back to 
Centiva Capital, LP
Centiva Capital, LP
MIRM
2 quarters
Position history for Centiva Capital, LP's holdings in Mirum Pharmaceuticals, Inc.
No. Centiva Capital exited its MIRM (Mirum Pharmaceuticals) position in Q3 2023. Its Q2 2023 13F listed 12,535 shares worth $324,280. Centiva Capital first reported MIRM in Q2 2023 and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$324,280
Total Shares Change
-12,535
Quarter-by-Quarter History
Other major holders of MIRM: Jupiter Topco LLC, Janus Henderson Group Ltd., BlackRock, Inc., FMR LLC